{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:19:49Z","timestamp":1783743589268,"version":"3.55.0"},"reference-count":39,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Haemophilia"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>To predict the long\u2010term benefits and economic costs of the improvements in haemophilia care in China demonstrated by increasing use of prophylaxis, compared with the current status.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>City\u2010level predictions from 2018 to 2033 were conducted for five representative cities in China. The long\u2010term clinical and economic outcomes in the scenario where haemophilia care has significantly improved and the existing scenario of haemophilia care were calculated and compared. The model input data were obtained from local records, expert interviews, published literature, and other sources. Outcome measures including number of bleeds and joint bleeds, number of target joints, disability rate, direct and indirect costs were calculated at the patient and population levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The long\u2010term predictions for 2033 demonstrated significantly improved bleed control and joint outcomes due to increased use of prophylaxis. The total number of averted bleed events per patient ranged from 3.9 in Shenyang to 16.1 in Zhengzhou in 2033, and the population\u2010level averted bleed events ranged from 1963 in Xiamen to 14,868 in Zhengzhou. The treatment improvement also leads to significant economic costs driven by increase in clotting factor costs (more than 90%). At the population level, the additional total costs were highest in Zhengzhou (CNY 177.4 million) and lowest in Shenyang (CNY 45.4 million), due to their different population sizes and various existing treatment regimens. The outpatient and hospitalization costs decreased, while the factor costs increased.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The long\u2010term prophylaxis is associated with avoided bleed events and disabilities. The improved treatment regimens are also associated with a significant economic burden, driven by factor costs.<\/jats:p><\/jats:sec>","DOI":"10.1111\/hae.14603","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T22:53:33Z","timestamp":1655506413000},"page":"726-736","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The long\u2010term clinical benefits and economic costs associated with increased use of prophylaxis among patients with haemophilia A in China: Population\u2010based predictions from 2018 to 2033"],"prefix":"10.1111","volume":"28","author":[{"given":"Xiaoning","family":"He","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Science and Technology Tianjin University  Tianjin China"},{"name":"Center for Social Science Survey and Data Tianjin University  Tianjin China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science and Technology Tianjin University  Tianjin China"},{"name":"Center for Social Science Survey and Data Tianjin University  Tianjin China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaohui","family":"Dong","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science and Technology Tianjin University  Tianjin China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Zhao","sequence":"additional","affiliation":[{"name":"The Department of Pharmacy Administration and Clinical Pharmacy School of Pharmacy Xi'an Jiaotong University  China"},{"name":"The Center for Drug Safety and Policy Research Xi'an Jiaotong University  China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Science and Technology Tianjin University  Tianjin China"},{"name":"Center for Social Science Survey and Data Tianjin University  Tianjin China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,6,17]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14046"},{"key":"e_1_2_9_3_1","first-page":"s126","article-title":"Economic costs of Haemophilia and the impact of prophylactic treatment on patient management","volume":"22","author":"Chen SL","year":"2016","journal-title":"Am J Manag Care"},{"key":"e_1_2_9_4_1","unstructured":"World Federation of Hemophilia.World Federation of Hemophilia report on the annual global survey 2018.https:\/\/www1.wfh.org\/publications\/files\/pdf\u20101731.pdf"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-7-24"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe078098"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2009.08.001"},{"key":"e_1_2_9_8_1","first-page":"S123","article-title":"Haemophilia in the managed care setting","volume":"21","author":"Dalton DR","year":"2015","journal-title":"Am J Manag Care"},{"key":"e_1_2_9_9_1","first-page":"55","article-title":"Cost\u2010utility analysis of prophylaxis versus treatment on demand in severe Haemophilia A","volume":"3","author":"Giorgio LC","year":"2011","journal-title":"Clinicoecon Outcomes Res"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200220110-00005"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2008.01821.x"},{"key":"e_1_2_9_12_1","unstructured":"China National Reimbursement Drug List 2020.http:\/\/www.gov.cn\/zhengce\/zhengceku\/2020\u201012\/28\/content_5574062.htm. Accessed June 12 2020."},{"key":"e_1_2_9_13_1","unstructured":"National Bureau of Statistics of China. 2020 China Statistical Yearbook.http:\/\/www.stats.gov.cn\/tjsj\/ndsj\/2020\/indexeh.htm. Accessed June 12 2020."},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1165-7"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-8121-2"},{"issue":"04","key":"e_1_2_9_16_1","first-page":"265","article-title":"Treatment Guideline of Haemophilia in China (2020)","year":"2020","journal-title":"Chin J Hematol"},{"key":"e_1_2_9_17_1","unstructured":"Statistical Bureau of Ningbo.Ningbo 2018 Statistical bulletin of national economic and social development.http:\/\/zfxx.ningbo.gov.cn\/art\/2019\/3\/31\/art_20713_3643986.html. Accessed July 7 2020."},{"key":"e_1_2_9_18_1","unstructured":"Statistical Bureau of Xiamen.Xiamen 2018 Statistical bulletin of national economic and social development.http:\/\/tjj.xm.gov.cn\/tjzl\/ndgb\/201903\/t20190322_2238302.htm. Accessed July 7 2020."},{"key":"e_1_2_9_19_1","unstructured":"Statistical Bureau of Tianjin.Tianjin 2018 Statistical bulletin of national economic and social development.http:\/\/www.tj.gov.cn\/sq\/tjgb\/202005\/t20200520_2468077.html. Accessed July 7 2020."},{"key":"e_1_2_9_20_1","unstructured":"Statistical Bureau of Shenyang.Shenyang 2018 Statistical bulletin of national economic and social development.http:\/\/www.shenyang.gov.cn\/html\/SY\/154700103578095\/154700103578095\/156047245207515\/0357809542058494.html. Accessed July 7 2020."},{"key":"e_1_2_9_21_1","unstructured":"Statistical Bureau of Zhengzhou.Zhengzhou 2018 Statistical bulletin of national economic and social development.http:\/\/tjj.zhengzhou.gov.cn\/tjgb\/3109505.jhtml. Accessed July 7 2020."},{"key":"e_1_2_9_22_1","first-page":"404","article-title":"Retrospectively analysis of the difference of bleeding frequency and hemophilic arthropathy between Haemophilia A and Haemophilia B patients","volume":"38","author":"Wang SX","year":"2017","journal-title":"Chinese J Hematol"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2012.02926.x"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000000389"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1080\/08880018.2017.1313921"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2017.1310720"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13198"},{"key":"e_1_2_9_28_1","first-page":"2406","article-title":"Comparison of efficacies of low\u2010dose prophylaxis on children and adults with severe Haemophilia A in China","author":"Li ZT","year":"2016","journal-title":"Guangdong Med J"},{"key":"e_1_2_9_29_1","first-page":"1391","article-title":"Breakthrough bleeding in adult patients with severe Haemophilia A receiving low\u2010 and intermediate\u2010dose FVIII for tertiary prophylaxis: characteristics and influencing factors","volume":"10","author":"Qiu SQ","year":"2017","journal-title":"J South Med Univ"},{"key":"e_1_2_9_30_1","first-page":"1222","article-title":"Efficacy of short\u2010term full\u2010dose prophylaxis in adult Chinese patients with severe Haemophilia A","volume":"38","author":"Sun X","year":"2018","journal-title":"J South Med Univ"},{"key":"e_1_2_9_31_1","first-page":"398","article-title":"Low\u2010dose tertiary prophylactic therapy for severe Haemophilia a adults in single medical center in Beijing area","volume":"37","author":"Lian XY","year":"2015","journal-title":"Acta Academiae Medicinae Sinicae"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13751"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12202"},{"key":"e_1_2_9_34_1","first-page":"496","article-title":"Prophylactic treatment with low\u2010and intermediate\u2010dose factor VIII in children with severe Haemophilia A: comprehensive evaluation of joint outcomes and correlation analysis","volume":"38","author":"Zhuang JM","year":"2018","journal-title":"J South Med Univ"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12859"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13302"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2015.1016228"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0660-y"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13372"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2018.24.7.632"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.14603","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/hae.14603","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/hae.14603","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T08:44:00Z","timestamp":1692693840000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/hae.14603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1111\/hae.14603"],"URL":"https:\/\/doi.org\/10.1111\/hae.14603","archive":["Portico"],"relation":{},"ISSN":["1351-8216","1365-2516"],"issn-type":[{"value":"1351-8216","type":"print"},{"value":"1365-2516","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,17]]},"assertion":[{"value":"2022-01-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-17","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}